
Insulet Investor Relations Material
Latest events

Q1 2025
Insulet
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Insulet Corporation
Access all reports
Insulet Corporation is a medical device company that develops and manufactures tubeless insulin pump systems for people with diabetes. Its flagship product is a wearable device that delivers continuous subcutaneous insulin infusion. The company markets its technology directly and through partnerships with healthcare providers. Insulet Corporation is headquartered in Acton, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Insulet Corporation


Q1 2025
Insulet Corporation


Q1 2025
Insulet Corporation
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PODD
Country
🇺🇸 United States